TECH: Rolling derisking, early signs of product-market fit
BIOTECH: Derisking comes in bursts over years (biological milestones), early signals less reliable
TECH: Outsourcing product development or engineering unadvisable
BIOTECH: Common to use contractors
BIOTECH: Markets are diseases and therefore public domain
TECH: Markets are winner-take-all
BIOTECH: Many winners
BIOTECH: Milestones center around biological de-risking
Of course, I've never built a tech co - LMK if you disagree or you notice any misconceptions!